Clinical Scenario Classification for Characterization and Outcome Prediction of Acute Decompensated Heart Failure

Jin Komuro1,2, Yuji Nagatomo1,3, Keitaro Mahara1

  • 1Department of Cardiology, Sakakibara Heart Institute Fuchu Japan.

Circulation Reports
|March 11, 2021
PubMed

Insights

Clinical Scenario (CS) classification aids acute decompensated heart failure (ADHF) management. While CS correlates with outcomes in HFrEF, its long-term prognostic value is limited in HFpEF, suggesting different underlying mechanisms.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Heart Failure Research

Background:

  • Clinical Scenario (CS) classification is used for acute decompensated heart failure (ADHF) management.
  • The West Tokyo-Heart Failure (WET-HF) Registry collected data on hospitalized ADHF patients.

Purpose of the Study:

  • To evaluate the prognostic value of CS classification based on admission systolic blood pressure (SBP) in ADHF patients.
  • To investigate the relationship between CS, left ventricular (LV) remodeling, and outcomes in HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF).

Main Methods:

  • Prospective cohort study of 4,000 hospitalized ADHF patients (2006-2017).
  • Patients classified into three CS groups based on admission SBP: CS1 (≥140 mmHg), CS2 (100-139 mmHg), CS3 (<100 mmHg).
  • Analysis of long-term all-cause death/ADHF re-hospitalization, body weight changes, diuretic use, and LV chamber size in relation to CS, stratified by ejection fraction.

Main Results:

  • CS1 patients showed higher fluid retention and greater weight reduction at discharge, with most frequent in-hospital diuretic use.
  • Long-term adverse events were more common in advanced CS groups, but no significant difference was observed in HFpEF patients.
  • Advanced CS correlated with larger LV size in HFrEF but smaller LV size in HFpEF.

Conclusions:

  • The long-term prognostic value of CS classification is limited in HFpEF.
  • CS is strongly associated with LV remodeling in HFrEF.
  • Smaller LV chamber size in HFpEF may indicate lower cardiovascular functional reserve.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
126
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
143
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
83
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
138
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
181